Registering a new trial?

To achieve prospective registration, we recommend submitting your trial for registration at the same time as ethics submission.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial details imported from ClinicalTrials.gov

For full trial details, please see the original record at https://clinicaltrials.gov/study/NCT01830543




Registration number
NCT01830543
Ethics application status
Date submitted
19/03/2013
Date registered
12/04/2013
Date last updated
19/09/2017

Titles & IDs
Public title
A Study Exploring Two Strategies of Rivaroxaban (JNJ39039039; BAY-59-7939) and One of Oral Vitamin K Antagonist in Patients With Atrial Fibrillation Who Undergo Percutaneous Coronary Intervention
Scientific title
An Open-label, Randomized, Controlled, Multicenter Study Exploring Two Treatment Strategies of Rivaroxaban and a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy in Subjects With Atrial Fibrillation Who Undergo Percutaneous Coronary Intervention
Secondary ID [1] 0 0
RIVAROXAFL3003
Secondary ID [2] 0 0
CR100758
Universal Trial Number (UTN)
Trial acronym
PIONEER AF-PCI
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Atrial Fibrillation 0 0
Percutaneous Coronary Intervention 0 0
Condition category
Condition code
Cardiovascular 0 0 0 0
Other cardiovascular diseases

Intervention/exposure
Study type
Interventional
Description of intervention(s) / exposure
Treatment: Drugs - rivaroxaban 2.5 mg
Treatment: Drugs - rivaroxaban 15 mg
Treatment: Drugs - rivaroxaban 10 mg
Treatment: Drugs - aspirin (ASA)
Treatment: Drugs - vitamin K antagonist (VKA)
Treatment: Drugs - clopidogrel
Treatment: Drugs - prasugrel
Treatment: Drugs - ticagrelor

Experimental: rivaroxaban 2.5 mg twice daily - rivaroxaban 2.5 mg tablet twice daily plus low-dose aspirin (ASA) 75 to 100 mg once daily and clopidogrel 75 mg tablet once daily (or prasugrel 10 mg tablet once daily or ticagrelor 90 mg tablet twice daily) followed by rivaroxaban 15 mg tablet (or 10 mg for subjects with moderate renal impairment) once daily plus low-dose ASA for 12 months

Experimental: vitamin K antagonist (VKA) - dose-adjusted vitamin K antagonist (VKA) once daily (target International Normalized Ratio (INR) 2.0 to 3.0) plus low-dose ASA, 75 to 100 mg per day, and clopidogrel 75 mg once daily (or prasugrel 10 mg tablet once daily or ticagrelor 90 mg tablet twice daily) followed by dose-adjusted VKA once daily (target INR 2.0 to 3.0 or 2.0 to 2.5 at the investigator discretion) plus low-dose ASA for 12 months

Experimental: rivaroxaban 15 mg once daily - rivaroxaban 15 mg (or 10 mg for subjects with moderate renal impairment) once daily plus clopidogrel 75 mg tablet once daily (or prasugrel 10 mg tablet once daily or ticagrelor 90 mg tablet twice daily) for 12 months


Treatment: Drugs: rivaroxaban 2.5 mg
One 2.5 mg tablet twice daily for up to twelve months

Treatment: Drugs: rivaroxaban 15 mg
One 15 mg tablet once daily for up to twelve months

Treatment: Drugs: rivaroxaban 10 mg
One 10 mg tablet once daily for up to twelve months

Treatment: Drugs: aspirin (ASA)
Low-dose aspirin tablet once daily for twelve months

Treatment: Drugs: vitamin K antagonist (VKA)
Dose-adjusted VKA tablet (target International Normalized Ratio (INR) 2.0 to 3.0) once daily for twelve months

Treatment: Drugs: clopidogrel
One 75 mg tablet once daily for up to twelve months

Treatment: Drugs: prasugrel
One 10 mg tablet once daily for up to twelve months

Treatment: Drugs: ticagrelor
One 90 mg tablet twice daily for up to twelve months

Intervention code [1] 0 0
Treatment: Drugs
Comparator / control treatment
Control group

Outcomes
Primary outcome [1] 0 0
Percentage of Participants With Clinically Significant Bleeding
Timepoint [1] 0 0
Up to Month 12
Secondary outcome [1] 0 0
Percentage of Participants With Thrombolysis in Myocardial Infarction (TIMI) Major Bleeding
Timepoint [1] 0 0
Up to Month 12 and end of DAPT-Month 1, 6 and 12
Secondary outcome [2] 0 0
Percentage of Participants With Thrombolysis in Myocardial Infarction (TIMI) Minor Bleeding
Timepoint [2] 0 0
Up to Month 12 and end of DAPT-Month 1, 6 and 12
Secondary outcome [3] 0 0
Percentage of Participants With Bleeding Requiring Medical Attention (BRMA)
Timepoint [3] 0 0
Up to Month 12 and end of DAPT-Month 1, 6 and 12
Secondary outcome [4] 0 0
Percentage of Participants With Composite of Adverse Cardiovascular Events (Cardiovascular Death, Myocardial Infarction (MI) and Stroke)
Timepoint [4] 0 0
Up to Month 12 and end of DAPT-Month 1, 6 and 12
Secondary outcome [5] 0 0
Percentage of Participants With Cardiovascular Death
Timepoint [5] 0 0
Up to Month 12 and end of DAPT-Month 1, 6 and 12
Secondary outcome [6] 0 0
Percentage of Participants With Myocardial Infarction
Timepoint [6] 0 0
Up to Month 12 and end of DAPT-Month 1, 6 and 12
Secondary outcome [7] 0 0
Percentage of Participants With Stroke
Timepoint [7] 0 0
Up to Month 12 and end of DAPT-Month 1, 6 and 12
Secondary outcome [8] 0 0
Percentage of Participants With Stent Thrombosis
Timepoint [8] 0 0
Up to Month 12 and end of DAPT-Month 1, 6 and 12

Eligibility
Key inclusion criteria
* Have a documented medical history of paroxysmal, persistent, or permanent non-valvular atrial fibrillation (AF)
* Have undergone percutaneous coronary intervention (PCI) procedure (with stent placement) for primary atherosclerotic disease
* Must have an international normalized ratio (INR) of 2.5 or below to be randomized
* Women must be postmenopausal before entry or practicing a highly effective method of birth control when heterosexually active
* Be willing and able to adhere to the prohibitions and restrictions specified in the study protocol
Minimum age
18 Years
Maximum age
No limit
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
* Have any condition that contraindicates anticoagulant or antiplatelet therapy or would have an unacceptable risk of bleeding, such as, but not limited to: platelet count <90,000/microliter at screening, history of intracranial hemorrhage, 12 month history of clinically significant gastrointestinal bleeding, non-VKA induced elevated prothrombin time (PT) at screening
* Have anemia of unknown cause with a hemoglobin level <10 g/dL (<6.21 mmol/L)
* Have a history of stroke or Transient Ischemic Attack (TIA)
* Have a calculated Creatinine Clearance (CrCl) <30 mL/min at screening
* Have known significant liver disease or liver function test (LFT) abnormalities
* Have any severe condition that would limit life expectancy to less than 12 months

Study design
Purpose of the study
Treatment
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Masking / blinding
Open (masking not used)
Who is / are masked / blinded?



Intervention assignment
Parallel
Other design features
Phase
Phase 3
Type of endpoint/s
Statistical methods / analysis

Recruitment
Recruitment status
Completed
Data analysis
Reason for early stopping/withdrawal
Other reasons
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
Recruitment hospital [1] 0 0
- Chermside N/A
Recruitment hospital [2] 0 0
- Epping
Recruitment hospital [3] 0 0
- Hobart
Recruitment hospital [4] 0 0
- Kogarah
Recruitment hospital [5] 0 0
- Liverpool
Recruitment hospital [6] 0 0
- New Lambton
Recruitment hospital [7] 0 0
- Wollongong
Recruitment postcode(s) [1] 0 0
- Chermside N/A
Recruitment postcode(s) [2] 0 0
- Epping
Recruitment postcode(s) [3] 0 0
- Hobart
Recruitment postcode(s) [4] 0 0
- Kogarah
Recruitment postcode(s) [5] 0 0
- Liverpool
Recruitment postcode(s) [6] 0 0
- New Lambton
Recruitment postcode(s) [7] 0 0
- Wollongong
Recruitment outside Australia
Country [1] 0 0
United States of America
State/province [1] 0 0
Alabama
Country [2] 0 0
United States of America
State/province [2] 0 0
California
Country [3] 0 0
United States of America
State/province [3] 0 0
Colorado
Country [4] 0 0
United States of America
State/province [4] 0 0
Connecticut
Country [5] 0 0
United States of America
State/province [5] 0 0
District of Columbia
Country [6] 0 0
United States of America
State/province [6] 0 0
Florida
Country [7] 0 0
United States of America
State/province [7] 0 0
Georgia
Country [8] 0 0
United States of America
State/province [8] 0 0
Idaho
Country [9] 0 0
United States of America
State/province [9] 0 0
Illinois
Country [10] 0 0
United States of America
State/province [10] 0 0
Indiana
Country [11] 0 0
United States of America
State/province [11] 0 0
Louisiana
Country [12] 0 0
United States of America
State/province [12] 0 0
Maine
Country [13] 0 0
United States of America
State/province [13] 0 0
Maryland
Country [14] 0 0
United States of America
State/province [14] 0 0
Michigan
Country [15] 0 0
United States of America
State/province [15] 0 0
Missouri
Country [16] 0 0
United States of America
State/province [16] 0 0
Montana
Country [17] 0 0
United States of America
State/province [17] 0 0
Nevada
Country [18] 0 0
United States of America
State/province [18] 0 0
New Jersey
Country [19] 0 0
United States of America
State/province [19] 0 0
New Mexico
Country [20] 0 0
United States of America
State/province [20] 0 0
New York
Country [21] 0 0
United States of America
State/province [21] 0 0
North Carolina
Country [22] 0 0
United States of America
State/province [22] 0 0
Oklahoma
Country [23] 0 0
United States of America
State/province [23] 0 0
Oregon
Country [24] 0 0
United States of America
State/province [24] 0 0
Pennsylvania
Country [25] 0 0
United States of America
State/province [25] 0 0
South Carolina
Country [26] 0 0
United States of America
State/province [26] 0 0
South Dakota
Country [27] 0 0
United States of America
State/province [27] 0 0
Tennessee
Country [28] 0 0
United States of America
State/province [28] 0 0
Texas
Country [29] 0 0
United States of America
State/province [29] 0 0
Utah
Country [30] 0 0
United States of America
State/province [30] 0 0
Virginia
Country [31] 0 0
United States of America
State/province [31] 0 0
Washington
Country [32] 0 0
United States of America
State/province [32] 0 0
Wisconsin
Country [33] 0 0
Argentina
State/province [33] 0 0
Bahia Blanca
Country [34] 0 0
Argentina
State/province [34] 0 0
Buenos Aires
Country [35] 0 0
Argentina
State/province [35] 0 0
C.a.b.a.
Country [36] 0 0
Argentina
State/province [36] 0 0
Cordoba
Country [37] 0 0
Argentina
State/province [37] 0 0
Corrientes
Country [38] 0 0
Argentina
State/province [38] 0 0
La Plata
Country [39] 0 0
Argentina
State/province [39] 0 0
Resistencia
Country [40] 0 0
Argentina
State/province [40] 0 0
Rosario
Country [41] 0 0
Argentina
State/province [41] 0 0
Santa Fe
Country [42] 0 0
Argentina
State/province [42] 0 0
Vicente Lopez
Country [43] 0 0
Belgium
State/province [43] 0 0
Aalst
Country [44] 0 0
Belgium
State/province [44] 0 0
Bonheiden
Country [45] 0 0
Belgium
State/province [45] 0 0
Brasschaat
Country [46] 0 0
Belgium
State/province [46] 0 0
Brugge
Country [47] 0 0
Belgium
State/province [47] 0 0
Bruxelles
Country [48] 0 0
Belgium
State/province [48] 0 0
Genk
Country [49] 0 0
Belgium
State/province [49] 0 0
Gent
Country [50] 0 0
Belgium
State/province [50] 0 0
Liège
Country [51] 0 0
Belgium
State/province [51] 0 0
Mechelen
Country [52] 0 0
Belgium
State/province [52] 0 0
Mol
Country [53] 0 0
Belgium
State/province [53] 0 0
Roeselare
Country [54] 0 0
Belgium
State/province [54] 0 0
Turnhout
Country [55] 0 0
Brazil
State/province [55] 0 0
Belo Horizonte
Country [56] 0 0
Brazil
State/province [56] 0 0
Blumenau
Country [57] 0 0
Brazil
State/province [57] 0 0
Brasilia
Country [58] 0 0
Brazil
State/province [58] 0 0
Campina Grande Do Sul
Country [59] 0 0
Brazil
State/province [59] 0 0
Campinas
Country [60] 0 0
Brazil
State/province [60] 0 0
Curitiba
Country [61] 0 0
Brazil
State/province [61] 0 0
Marilia
Country [62] 0 0
Brazil
State/province [62] 0 0
Passo Fundo
Country [63] 0 0
Brazil
State/province [63] 0 0
Porto Alegre
Country [64] 0 0
Brazil
State/province [64] 0 0
Recife
Country [65] 0 0
Brazil
State/province [65] 0 0
Sao Paulo
Country [66] 0 0
Brazil
State/province [66] 0 0
São José Do Rio Preto
Country [67] 0 0
Brazil
State/province [67] 0 0
São Paulo
Country [68] 0 0
Brazil
State/province [68] 0 0
Uberlandia
Country [69] 0 0
Brazil
State/province [69] 0 0
Votuporanga
Country [70] 0 0
Bulgaria
State/province [70] 0 0
Blagoevgrad
Country [71] 0 0
Bulgaria
State/province [71] 0 0
Burgas
Country [72] 0 0
Bulgaria
State/province [72] 0 0
Pazardjik
Country [73] 0 0
Bulgaria
State/province [73] 0 0
Pleven
Country [74] 0 0
Bulgaria
State/province [74] 0 0
Plovdiv
Country [75] 0 0
Bulgaria
State/province [75] 0 0
Sofia
Country [76] 0 0
Bulgaria
State/province [76] 0 0
Varna
Country [77] 0 0
Bulgaria
State/province [77] 0 0
Veliko Tarnovo
Country [78] 0 0
Canada
State/province [78] 0 0
Alberta
Country [79] 0 0
Canada
State/province [79] 0 0
British Columbia
Country [80] 0 0
Canada
State/province [80] 0 0
Newfoundland and Labrador
Country [81] 0 0
Canada
State/province [81] 0 0
Ontario
Country [82] 0 0
Canada
State/province [82] 0 0
Quebec
Country [83] 0 0
Canada
State/province [83] 0 0
Chicoutimi
Country [84] 0 0
Canada
State/province [84] 0 0
Saint John
Country [85] 0 0
Chile
State/province [85] 0 0
Alto
Country [86] 0 0
Chile
State/province [86] 0 0
Concepcion
Country [87] 0 0
Chile
State/province [87] 0 0
Punta Arenas
Country [88] 0 0
Chile
State/province [88] 0 0
Santiago
Country [89] 0 0
Chile
State/province [89] 0 0
Temuco
Country [90] 0 0
Czechia
State/province [90] 0 0
Brno 2
Country [91] 0 0
Czechia
State/province [91] 0 0
Brno
Country [92] 0 0
Czechia
State/province [92] 0 0
Hradec Kralove
Country [93] 0 0
Czechia
State/province [93] 0 0
Jablonec Na Nisou
Country [94] 0 0
Czechia
State/province [94] 0 0
Karlovy Vary
Country [95] 0 0
Czechia
State/province [95] 0 0
Kladno
Country [96] 0 0
Czechia
State/province [96] 0 0
Litomysl
Country [97] 0 0
Czechia
State/province [97] 0 0
Olomouc
Country [98] 0 0
Czechia
State/province [98] 0 0
Plzen
Country [99] 0 0
Czechia
State/province [99] 0 0
Praha 10 N/A
Country [100] 0 0
Czechia
State/province [100] 0 0
Praha 2
Country [101] 0 0
Czechia
State/province [101] 0 0
Praha
Country [102] 0 0
Czechia
State/province [102] 0 0
Slany
Country [103] 0 0
Czechia
State/province [103] 0 0
Uherske Hradiste
Country [104] 0 0
Denmark
State/province [104] 0 0
Aalborg
Country [105] 0 0
Denmark
State/province [105] 0 0
Copenhagen
Country [106] 0 0
Denmark
State/province [106] 0 0
Esbjerg
Country [107] 0 0
Denmark
State/province [107] 0 0
Herlev
Country [108] 0 0
Denmark
State/province [108] 0 0
Herning
Country [109] 0 0
Denmark
State/province [109] 0 0
Hvidovre
Country [110] 0 0
Denmark
State/province [110] 0 0
Koege
Country [111] 0 0
Denmark
State/province [111] 0 0
Naestved
Country [112] 0 0
Denmark
State/province [112] 0 0
Odense
Country [113] 0 0
Denmark
State/province [113] 0 0
Roskilde
Country [114] 0 0
Denmark
State/province [114] 0 0
Svendborg N/A
Country [115] 0 0
Denmark
State/province [115] 0 0
Vejle
Country [116] 0 0
France
State/province [116] 0 0
Besancon Cedex Franche-Comté
Country [117] 0 0
France
State/province [117] 0 0
Caen Cedex 9
Country [118] 0 0
France
State/province [118] 0 0
Centres
Country [119] 0 0
France
State/province [119] 0 0
Chartres
Country [120] 0 0
France
State/province [120] 0 0
Lille
Country [121] 0 0
France
State/province [121] 0 0
Limoges Cedex
Country [122] 0 0
France
State/province [122] 0 0
Marseille Cedex 05
Country [123] 0 0
France
State/province [123] 0 0
Montfermeil
Country [124] 0 0
France
State/province [124] 0 0
Nantes Cedex 1
Country [125] 0 0
France
State/province [125] 0 0
Nimes
Country [126] 0 0
France
State/province [126] 0 0
Paris 75
Country [127] 0 0
France
State/province [127] 0 0
Paris
Country [128] 0 0
France
State/province [128] 0 0
Pau
Country [129] 0 0
France
State/province [129] 0 0
Pessac
Country [130] 0 0
France
State/province [130] 0 0
Poitiers
Country [131] 0 0
France
State/province [131] 0 0
Toulouse
Country [132] 0 0
Germany
State/province [132] 0 0
Bad Friedrichshall
Country [133] 0 0
Germany
State/province [133] 0 0
Bad Nauheim
Country [134] 0 0
Germany
State/province [134] 0 0
Berlin
Country [135] 0 0
Germany
State/province [135] 0 0
Dresden
Country [136] 0 0
Germany
State/province [136] 0 0
Esslingen
Country [137] 0 0
Germany
State/province [137] 0 0
Frankfurt Am Main
Country [138] 0 0
Germany
State/province [138] 0 0
Freiburg
Country [139] 0 0
Germany
State/province [139] 0 0
Greifswald
Country [140] 0 0
Germany
State/province [140] 0 0
Göttingen
Country [141] 0 0
Germany
State/province [141] 0 0
Hamburg
Country [142] 0 0
Germany
State/province [142] 0 0
Heidelberg
Country [143] 0 0
Germany
State/province [143] 0 0
Köln
Country [144] 0 0
Germany
State/province [144] 0 0
Limburg
Country [145] 0 0
Germany
State/province [145] 0 0
Mannheim
Country [146] 0 0
Germany
State/province [146] 0 0
Ulm
Country [147] 0 0
Germany
State/province [147] 0 0
Witten
Country [148] 0 0
Korea, Republic of
State/province [148] 0 0
Busan
Country [149] 0 0
Korea, Republic of
State/province [149] 0 0
Daejeon
Country [150] 0 0
Korea, Republic of
State/province [150] 0 0
Gyeonggi-Do
Country [151] 0 0
Korea, Republic of
State/province [151] 0 0
Incheon
Country [152] 0 0
Korea, Republic of
State/province [152] 0 0
Seongnam
Country [153] 0 0
Korea, Republic of
State/province [153] 0 0
Seoul
Country [154] 0 0
Korea, Republic of
State/province [154] 0 0
Suwon
Country [155] 0 0
Korea, Republic of
State/province [155] 0 0
Uijeongbu
Country [156] 0 0
Korea, Republic of
State/province [156] 0 0
Wonju
Country [157] 0 0
Malaysia
State/province [157] 0 0
Georgetown
Country [158] 0 0
Malaysia
State/province [158] 0 0
Johor Bahru
Country [159] 0 0
Malaysia
State/province [159] 0 0
Kajang
Country [160] 0 0
Malaysia
State/province [160] 0 0
Kuala Lumpur
Country [161] 0 0
Mexico
State/province [161] 0 0
Aguascalientes
Country [162] 0 0
Mexico
State/province [162] 0 0
Guadalajara
Country [163] 0 0
Mexico
State/province [163] 0 0
Leon
Country [164] 0 0
Mexico
State/province [164] 0 0
Mexico
Country [165] 0 0
Mexico
State/province [165] 0 0
Pachuca
Country [166] 0 0
Mexico
State/province [166] 0 0
Puebla
Country [167] 0 0
Mexico
State/province [167] 0 0
Queretaro
Country [168] 0 0
Mexico
State/province [168] 0 0
Villahermosa
Country [169] 0 0
Mexico
State/province [169] 0 0
Zapopan
Country [170] 0 0
Netherlands
State/province [170] 0 0
Alkmaar
Country [171] 0 0
Netherlands
State/province [171] 0 0
Amsterdam Zuidoost
Country [172] 0 0
Netherlands
State/province [172] 0 0
Amsterdam
Country [173] 0 0
Netherlands
State/province [173] 0 0
Breda
Country [174] 0 0
Netherlands
State/province [174] 0 0
Delft
Country [175] 0 0
Netherlands
State/province [175] 0 0
Den Bosch
Country [176] 0 0
Netherlands
State/province [176] 0 0
Gorinchem
Country [177] 0 0
Netherlands
State/province [177] 0 0
Leiden
Country [178] 0 0
Netherlands
State/province [178] 0 0
Maastricht
Country [179] 0 0
Netherlands
State/province [179] 0 0
Nieuwegein
Country [180] 0 0
Netherlands
State/province [180] 0 0
Sneek
Country [181] 0 0
Netherlands
State/province [181] 0 0
Uden
Country [182] 0 0
Poland
State/province [182] 0 0
Bedzin
Country [183] 0 0
Poland
State/province [183] 0 0
Bielsko-Biala
Country [184] 0 0
Poland
State/province [184] 0 0
Chrzanow
Country [185] 0 0
Poland
State/province [185] 0 0
Gdynia
Country [186] 0 0
Poland
State/province [186] 0 0
Grodzisk Mazowiecki
Country [187] 0 0
Poland
State/province [187] 0 0
Katowice
Country [188] 0 0
Poland
State/province [188] 0 0
Krakow
Country [189] 0 0
Poland
State/province [189] 0 0
Lodz
Country [190] 0 0
Poland
State/province [190] 0 0
Mielec
Country [191] 0 0
Poland
State/province [191] 0 0
Nowy Targ
Country [192] 0 0
Poland
State/province [192] 0 0
Ostrowiec Swietokrzyski
Country [193] 0 0
Poland
State/province [193] 0 0
Oswiecim
Country [194] 0 0
Poland
State/province [194] 0 0
Plock
Country [195] 0 0
Poland
State/province [195] 0 0
Rzeszow Poland
Country [196] 0 0
Poland
State/province [196] 0 0
Starachowice
Country [197] 0 0
Poland
State/province [197] 0 0
Starogard Gdanski
Country [198] 0 0
Poland
State/province [198] 0 0
Szczecin
Country [199] 0 0
Poland
State/province [199] 0 0
Torun
Country [200] 0 0
Poland
State/province [200] 0 0
Tychy
Country [201] 0 0
Poland
State/province [201] 0 0
Ustron
Country [202] 0 0
Poland
State/province [202] 0 0
Warszawa
Country [203] 0 0
Poland
State/province [203] 0 0
Zamosc
Country [204] 0 0
Romania
State/province [204] 0 0
Bucharest
Country [205] 0 0
Romania
State/province [205] 0 0
Bucuresti
Country [206] 0 0
Romania
State/province [206] 0 0
Cluj Napoca
Country [207] 0 0
Romania
State/province [207] 0 0
Targu-Mures
Country [208] 0 0
Romania
State/province [208] 0 0
Tg Mures
Country [209] 0 0
Russian Federation
State/province [209] 0 0
Arkhangelsk
Country [210] 0 0
Russian Federation
State/province [210] 0 0
Barnaul
Country [211] 0 0
Russian Federation
State/province [211] 0 0
Chita
Country [212] 0 0
Russian Federation
State/province [212] 0 0
Ekaterinburg
Country [213] 0 0
Russian Federation
State/province [213] 0 0
Kemerovo
Country [214] 0 0
Russian Federation
State/province [214] 0 0
Krasnodar
Country [215] 0 0
Russian Federation
State/province [215] 0 0
Krasnoyarsk
Country [216] 0 0
Russian Federation
State/province [216] 0 0
Moscow
Country [217] 0 0
Russian Federation
State/province [217] 0 0
Nizhny Novgorod
Country [218] 0 0
Russian Federation
State/province [218] 0 0
Perm
Country [219] 0 0
Russian Federation
State/province [219] 0 0
Rostov On Don
Country [220] 0 0
Russian Federation
State/province [220] 0 0
Samara
Country [221] 0 0
Russian Federation
State/province [221] 0 0
Saratov
Country [222] 0 0
Russian Federation
State/province [222] 0 0
St. Petersburg
Country [223] 0 0
Russian Federation
State/province [223] 0 0
Syktyvkar
Country [224] 0 0
Russian Federation
State/province [224] 0 0
Tumen
Country [225] 0 0
Russian Federation
State/province [225] 0 0
Tyumen
Country [226] 0 0
South Africa
State/province [226] 0 0
Cape Town
Country [227] 0 0
South Africa
State/province [227] 0 0
Centurion
Country [228] 0 0
South Africa
State/province [228] 0 0
Linksfield West, Johannesburg
Country [229] 0 0
South Africa
State/province [229] 0 0
Somerset West
Country [230] 0 0
Sweden
State/province [230] 0 0
Falun
Country [231] 0 0
Sweden
State/province [231] 0 0
Göteborg
Country [232] 0 0
Sweden
State/province [232] 0 0
Jönköping
Country [233] 0 0
Sweden
State/province [233] 0 0
Lund
Country [234] 0 0
Sweden
State/province [234] 0 0
Malmö
Country [235] 0 0
Sweden
State/province [235] 0 0
Stockholm N/A
Country [236] 0 0
Sweden
State/province [236] 0 0
Stockholm
Country [237] 0 0
Sweden
State/province [237] 0 0
Umeå
Country [238] 0 0
Sweden
State/province [238] 0 0
Örebro
Country [239] 0 0
Taiwan
State/province [239] 0 0
Kaohsiung
Country [240] 0 0
Taiwan
State/province [240] 0 0
Taichung
Country [241] 0 0
Taiwan
State/province [241] 0 0
Tainan
Country [242] 0 0
Taiwan
State/province [242] 0 0
Taipei
Country [243] 0 0
Taiwan
State/province [243] 0 0
Taoyuan
Country [244] 0 0
Turkey
State/province [244] 0 0
Ankara
Country [245] 0 0
Turkey
State/province [245] 0 0
Antalya
Country [246] 0 0
Turkey
State/province [246] 0 0
Bursa
Country [247] 0 0
Turkey
State/province [247] 0 0
Gaziantep
Country [248] 0 0
Turkey
State/province [248] 0 0
Istanbul Nap
Country [249] 0 0
Turkey
State/province [249] 0 0
Istanbul
Country [250] 0 0
Turkey
State/province [250] 0 0
Izmir
Country [251] 0 0
Turkey
State/province [251] 0 0
Kayseri
Country [252] 0 0
Turkey
State/province [252] 0 0
Sivas
Country [253] 0 0
Ukraine
State/province [253] 0 0
Cherkassy
Country [254] 0 0
Ukraine
State/province [254] 0 0
Dnepropetrovsk
Country [255] 0 0
Ukraine
State/province [255] 0 0
Ivano-Frankivsk
Country [256] 0 0
Ukraine
State/province [256] 0 0
Kharkiv
Country [257] 0 0
Ukraine
State/province [257] 0 0
Kharkov
Country [258] 0 0
Ukraine
State/province [258] 0 0
Khemelnitskiy
Country [259] 0 0
Ukraine
State/province [259] 0 0
Kyiv
Country [260] 0 0
Ukraine
State/province [260] 0 0
Lviv
Country [261] 0 0
Ukraine
State/province [261] 0 0
Odessa
Country [262] 0 0
Ukraine
State/province [262] 0 0
Rivne
Country [263] 0 0
Ukraine
State/province [263] 0 0
Uzhgorod
Country [264] 0 0
Ukraine
State/province [264] 0 0
Zaporizhzhya
Country [265] 0 0
United Kingdom
State/province [265] 0 0
Bath
Country [266] 0 0
United Kingdom
State/province [266] 0 0
Birmingham
Country [267] 0 0
United Kingdom
State/province [267] 0 0
Blackburn
Country [268] 0 0
United Kingdom
State/province [268] 0 0
Bradford
Country [269] 0 0
United Kingdom
State/province [269] 0 0
Clydebank
Country [270] 0 0
United Kingdom
State/province [270] 0 0
Cottingham
Country [271] 0 0
United Kingdom
State/province [271] 0 0
Coventry
Country [272] 0 0
United Kingdom
State/province [272] 0 0
Dorchester
Country [273] 0 0
United Kingdom
State/province [273] 0 0
Dundee
Country [274] 0 0
United Kingdom
State/province [274] 0 0
Edinburgh
Country [275] 0 0
United Kingdom
State/province [275] 0 0
Exeter
Country [276] 0 0
United Kingdom
State/province [276] 0 0
Hampshire
Country [277] 0 0
United Kingdom
State/province [277] 0 0
Harrow
Country [278] 0 0
United Kingdom
State/province [278] 0 0
High Wycombe
Country [279] 0 0
United Kingdom
State/province [279] 0 0
London
Country [280] 0 0
United Kingdom
State/province [280] 0 0
Middlesbrough N/A
Country [281] 0 0
United Kingdom
State/province [281] 0 0
Norwich
Country [282] 0 0
United Kingdom
State/province [282] 0 0
Nottingham
Country [283] 0 0
United Kingdom
State/province [283] 0 0
Plymouth
Country [284] 0 0
United Kingdom
State/province [284] 0 0
Portsmouth
Country [285] 0 0
United Kingdom
State/province [285] 0 0
Torquay
Country [286] 0 0
United Kingdom
State/province [286] 0 0
Truro
Country [287] 0 0
United Kingdom
State/province [287] 0 0
Worcester

Funding & Sponsors
Primary sponsor type
Commercial sector/industry
Name
Janssen Scientific Affairs, LLC
Address
Country
Other collaborator category [1] 0 0
Commercial sector/industry
Name [1] 0 0
Bayer
Address [1] 0 0
Country [1] 0 0

Ethics approval
Ethics application status

Summary
Brief summary
The primary purpose of this study is to evaluate the safety for 2 different rivaroxaban treatment strategies and one Vitamin K Antagonist (VKA) treatment strategy utilizing various combinations of dual antiplatelet therapy (DAPT) or low-dose aspirin (ASA) or clopidogrel (or prasugrel or ticagrelor).
Trial website
https://clinicaltrials.gov/study/NCT01830543
Trial related presentations / publications
Kerneis M, Yee MK, Mehran R, Nafee T, Bode C, Halperin JL, Peterson ED, Verheugt FWA, Wildgoose P, van Eickels M, Lip GYH, Cohen M, Fox KAA, Gibson CM. Novel Oral Anticoagulant Based Versus Vitamin K Antagonist Based Double Therapy Among Stented Patients With Atrial Fibrillation: Insights From the PIONEER AF-PCI Trial. Circ Cardiovasc Interv. 2019 Nov;12(11):e008160. doi: 10.1161/CIRCINTERVENTIONS.119.008160. Epub 2019 Nov 11.
Gibson WJ, Nafee T, Travis R, Yee M, Kerneis M, Ohman M, Gibson CM. Machine learning versus traditional risk stratification methods in acute coronary syndrome: a pooled randomized clinical trial analysis. J Thromb Thrombolysis. 2020 Jan;49(1):1-9. doi: 10.1007/s11239-019-01940-8.
Kerneis M, Yee MK, Mehran R, Nafee T, Bode C, Halperin JL, Peterson ED, Verheugt FWA, Wildgoose P, van Eickels M, Lip GYH, Cohen M, Fox KAA, Gibson CM. Association of International Normalized Ratio Stability and Bleeding Outcomes Among Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention. Circ Cardiovasc Interv. 2019 Feb;12(2):e007124. doi: 10.1161/CIRCINTERVENTIONS.118.007124.
Chi G, Kerneis M, Kalayci A, Liu Y, Mehran R, Bode C, Halperin JL, Verheugt FWA, Wildgoose P, van Eickels M, Lip GYH, Cohen M, Peterson ED, Fox KAA, Gibson CM. Safety and efficacy of non-vitamin K oral anticoagulant for atrial fibrillation patients after percutaneous coronary intervention: A bivariate analysis of the PIONEER AF-PCI and RE-DUAL PCI trial. Am Heart J. 2018 Sep;203:17-24. doi: 10.1016/j.ahj.2018.06.003. Epub 2018 Jun 13.
Chi G, Yee MK, Kalayci A, Kerneis M, AlKhalfan F, Mehran R, Bode C, Halperin JL, Verheugt FWA, Wildgoose P, van Eickels M, Lip GYH, Cohen M, Peterson ED, Fox KAA, Gibson CM. Total bleeding with rivaroxaban versus warfarin in patients with atrial fibrillation receiving antiplatelet therapy after percutaneous coronary intervention. J Thromb Thrombolysis. 2018 Oct;46(3):346-350. doi: 10.1007/s11239-018-1703-5.
Kerneis M, Gibson CM, Chi G, Mehran R, AlKhalfan F, Talib U, Pahlavani S, Mir M, Bode C, Halperin JL, Nafee T, Peterson ED, Verheugt FWA, Wildgoose P, van Eickels M, Lip GYH, Fox KAA, Cohen M. Effect of Procedure and Coronary Lesion Characteristics on Clinical Outcomes Among Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention: Insights From the PIONEER AF-PCI Trial. JACC Cardiovasc Interv. 2018 Apr 9;11(7):626-634. doi: 10.1016/j.jcin.2017.11.009. Epub 2018 Mar 14.
Gibson CM, Mehran R, Bode C, Halperin J, Verheugt FW, Wildgoose P, Birmingham M, Ianus J, Burton P, van Eickels M, Korjian S, Daaboul Y, Lip GY, Cohen M, Husted S, Peterson ED, Fox KA. Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI. N Engl J Med. 2016 Dec 22;375(25):2423-2434. doi: 10.1056/NEJMoa1611594. Epub 2016 Nov 14.
Gibson CM, Pinto DS, Chi G, Arbetter D, Yee M, Mehran R, Bode C, Halperin J, Verheugt FW, Wildgoose P, Burton P, van Eickels M, Korjian S, Daaboul Y, Jain P, Lip GY, Cohen M, Peterson ED, Fox KA. Recurrent Hospitalization Among Patients With Atrial Fibrillation Undergoing Intracoronary Stenting Treated With 2 Treatment Strategies of Rivaroxaban or a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy. Circulation. 2017 Jan 24;135(4):323-333. doi: 10.1161/CIRCULATIONAHA.116.025783. Epub 2016 Nov 14. Erratum In: Circulation. 2017 Mar 21;135(12):e789. doi: 10.1161/CIR.0000000000000495.
Gibson CM, Mehran R, Bode C, Halperin J, Verheugt F, Wildgoose P, van Eickels M, Lip GY, Cohen M, Husted S, Peterson E, Fox K. An open-label, randomized, controlled, multicenter study exploring two treatment strategies of rivaroxaban and a dose-adjusted oral vitamin K antagonist treatment strategy in subjects with atrial fibrillation who undergo percutaneous coronary intervention (PIONEER AF-PCI). Am Heart J. 2015 Apr;169(4):472-8.e5. doi: 10.1016/j.ahj.2014.12.006. Epub 2014 Dec 20.
Public notes

Contacts
Principal investigator
Name 0 0
Janssen Scientific Affairs, LLC Clinical Trial
Address 0 0
Janssen Scientific Affairs, LLC
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for public queries
Name 0 0
Address 0 0
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for scientific queries



Summary Results

For IPD and results data, please see https://clinicaltrials.gov/study/NCT01830543